Sustiva (efavirenz)

DRUG2 trials

Sponsors

Abbott, Gilead Sciences

Conditions

HIV InfectionHIV InfectionsHepatitis C

Phase 2

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

WithdrawnNCT00121017

AbbottHepatitis C, HIV Infection

Target: 200Updated: 2006-07-27

Phase 3

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

CompletedNCT00158821

Gilead SciencesHIV Infections

Start: 2000-03-31End: 2013-06-30Target: 180Updated: 2013-06-25